. Author manuscript; available in PMC: 2017 Jun 1.

Published in final edited form as: Cancer Metastasis Rev. 2016 Jun;35(2):263–275. doi: 10.1007/s10555-016-9602-8

Table 1.

Current treatment strategies in biliary tract cancers

Clinical situation	Treatment	Median survival
Resectable disease (adjuvant)	Surgical resection; followed by:	33 months
	Fluoropyrimidine-based chemoradiation, or fluoropyrimidine or gemcitabine chemotherapy, or observation
Unresectable disease	Gemcitabine + Cisplatin	11.7 months
	Fluoropyrimidine-based chemoradiation	9.8 months
Metastatic disease	Gemcitabine + Cisplatin	11.7 months
	Fluoropyrimidine- or gemcitabine-based chemotherapy	5.1 to 15.4 months